We are live on ! Find out more
FBB

Fulton Breakefield Broenniman Portfolio holdings

AUM $1.53B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
-1.7%
1 Year Est. Return
+18.11%
3 Year Est. Return
+57.23%
5 Year Est. Return
+68.56%
10 Year Est. Return
+240.26%
AUM
$457M
AUM Growth
+$7.93M
Cap. Flow
+$16.1M
Cap. Flow %
3.53%
Top 10 Hldgs %
19.67%
Holding
135
New
8
Increased
72
Reduced
37
Closed
13

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$6.03M
2
UNH icon
UnitedHealth
UNH
+$5.81M
3
CERN
Cerner Corp
CERN
+$4.96M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$4.4M
5
AAPL icon
Apple
AAPL
+$4.26M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.22%
2 Healthcare 13.18%
3 Consumer Staples 10.82%
4 Technology 9.75%
5 Financials 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
26
Amgen
AMGN
$208B
$6.61M 1.45%
43,039
+1,131
+3% +$181K
BAC icon
27
Bank of America
BAC
$435B
$6.47M 1.42%
380,346
-8,800
-2% -$145K
TNL icon
28
Travel + Leisure Co
TNL
$4.66B
$6.39M 1.4%
172,801
+1,488
+0.9% +$58.3K
V icon
29
Visa
V
$684B
$6.29M 1.38%
93,620
+1,913
+2% +$130K
PNC icon
30
PNC Financial Services
PNC
$99.7B
$6.24M 1.36%
65,208
+43,961
+207% +$4.16M
UL icon
31
Unilever
UL
$137B
$6.16M 1.35%
127,491
+230
+0.2% +$11.4K
GOOG icon
32
Alphabet (Google) Class C
GOOG
$4.36T
$6.11M 1.34%
226,220
+7,501
+3% +$201K
DHR icon
33
Danaher
DHR
$137B
$6.05M 1.32%
+105,236
New +$6.03M
UNH icon
34
UnitedHealth
UNH
$376B
$5.99M 1.31%
+49,122
New +$5.81M
CVX icon
35
Chevron
CVX
$392B
$5.72M 1.25%
59,314
+331
+0.6% +$34.8K
ICF icon
36
iShares Select U.S. REIT ETF
ICF
$2.09B
$5.66M 1.24%
126,400
+4,920
+4% +$236K
MCHP icon
37
Microchip Technology
MCHP
$40.3B
$5.63M 1.23%
237,548
-5,732
-2% -$139K
MCD icon
38
McDonald's
MCD
$192B
$5.55M 1.21%
58,396
-136
-0.2% -$13.2K
NKE icon
39
Nike
NKE
$61.9B
$5.52M 1.21%
102,166
+3,260
+3% +$167K
DOV icon
40
Dover
DOV
$27.6B
$5.48M 1.2%
96,646
-1,889
-2% -$112K
INTC icon
41
Intel
INTC
$455B
$5.44M 1.19%
178,727
+1,586
+0.9% +$51.3K
CERN
42
DELISTED
Cerner Corp
CERN
$4.89M 1.07%
+70,849
New +$4.96M
XOM icon
43
ExxonMobil
XOM
$644B
$4.82M 1.05%
57,940
-1,463
-2% -$126K
NEE icon
44
NextEra Energy
NEE
$181B
$4.79M 1.05%
195,348
+712
+0.4% +$18.1K
T icon
45
AT&T
T
$159B
$4.73M 1.04%
176,355
-1,139
-0.6% -$29.4K
ALXN
46
DELISTED
Alexion Pharmaceuticals
ALXN
$4.61M 1.01%
+25,507
New +$4.4M
XEL icon
47
Xcel Energy
XEL
$48.8B
$4.57M 1%
142,097
+263
+0.2% +$8.85K
GPC icon
48
Genuine Parts
GPC
$17.1B
$4.52M 0.99%
50,518
+1,362
+3% +$125K
IBB icon
49
iShares Biotechnology ETF
IBB
$9.34B
$4.33M 0.95%
35,169
-381
-1% -$45.6K
NVS icon
50
Novartis
NVS
$297B
$4.23M 0.93%
48,013
+1,668
+4% +$153K

Similar funds

Fulton Breakefield Broenniman's Q2 2015 Portfolio in Review

As of Q2 2015, Fulton Breakefield Broenniman held 135 positions worth $457M, up 1.8% from $449M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Fulton Breakefield Broenniman deployed $16.1M of net new capital in Q2 2015, opening 8 new positions and adding to 72 existing holdings. Its largest new stake was Danaher: 105,236 shares worth $6.05M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Procter & Gamble, an estimated $257K trimmed.

  • Fulton Breakefield Broenniman's largest Q2 2015 buy was Danaher: 105,236 shares worth $6.05M.
  • Fulton Breakefield Broenniman added most to Apple in Q2 2015, an estimated $4.26M increase.
  • Fulton Breakefield Broenniman's biggest Q2 2015 reduction was Procter & Gamble, cutting an estimated $257K.
  • Fulton Breakefield Broenniman fully exited Emerson Electric in Q2 2015, selling an estimated $5.8M.
  • Fulton Breakefield Broenniman's ten largest holdings make up 20% of its $457M portfolio in Q2 2015.
  • Fulton Breakefield Broenniman opened 8 new positions and closed 13 in Q2 2015.
  • Fulton Breakefield Broenniman's portfolio value rose 1.8% quarter-over-quarter to $457M.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2015, filed 4 Aug 2015.